Korean J Ophthalmol.  2010 Jun;24(3):192-193. 10.3341/kjo.2010.24.3.192.

Bevacizumab and Triamcinolone for Branch Vein Occlusion

• Wong IY

• KMID: 945995
• DOI: http://doi.org/10.3341/kjo.2010.24.3.192

Abstract

No abstract available.

MeSH Terms

Aged
Angiogenesis Inhibitors/*administration & dosage
Antibodies, Monoclonal/*administration & dosage
Female
Glucocorticoids/*administration & dosage
Humans
Injections, Intraocular
Macular Edema/*drug therapy/etiology
Male
Middle Aged
Retinal Vein Occlusion/*complications
Triamcinolone Acetonide/*administration & dosage
Vitreous Body

Reference

1. Kim JY, Park SP. Comparison between intravitreal bevacizumab and triamcinolone for macular edema secondary to branch retinal vein occlusion. Korean J Ophthalmol. 2009. 23:259–265.

2. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984. 98:271–282.

3. Scott IU, Ip MS, Van Veldhuisen PC, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol. 2009. 127:1115–1128.